Tanner J. Caverly, MD, MPH; Rafael Meza, PhD
Acknowledgment: The authors thank Rodney Hayward and Jeremy Sussman for reviewing the ideas in this manuscript.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2869.
Corresponding Author: Tanner J. Caverly, MD, MPH, VA Center for Clinical Management Research and University of Michigan Medical School, 2800 Plymouth Road, Building 16, Room 331, Ann Arbor, MI 48109-2800; e-mail, email@example.com.
Current Author Addresses: Dr. Caverly: VA Center for Clinical Management Research and University of Michigan Medical School, 2800 Plymouth Road, Building 16, Room 331, Ann Arbor, MI 48109-2800.
Dr. Meza: Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029.
Caverly TJ, Meza R. Using Risk Models to Make Lung Cancer Screening Decisions: Evidence-Based and Getting Better. Ann Intern Med. 2019;171:669–670. [Epub ahead of print 22 October 2019]. doi: https://doi.org/10.7326/M19-2869
Download citation file:
Published: Ann Intern Med. 2019;171(9):669-670.
Published at www.annals.org on 22 October 2019
Cancer Screening/Prevention, Hematology/Oncology, Lung Cancer, Prevention/Screening, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use